22.03
-0.04
(-0.18%)
As of 10:39:12 AM EST. Market Open.
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-271,643.00
-214,227.00
-188,193.00
-106,112.00
-83,327.00
Investing Cash Flow
-659.00
-360.00
-197.00
-254.00
-210.00
Financing Cash Flow
472,805.00
472,427.00
70,885.00
200,129.00
383,112.00
End Cash Position
470,431.00
635,365.00
376,532.00
493,817.00
400,146.00
Income Tax Paid Supplemental Data
810.00
509.00
--
--
166.00
Capital Expenditure
-659.00
-360.00
-197.00
-254.00
-210.00
Issuance of Capital Stock
--
472,745.00
70,500.00
--
319,783.00
Repayment of Debt
--
--
--
--
-3,190.00
Free Cash Flow
-272,302.00
-214,587.00
-188,390.00
-106,366.00
-83,537.00
3/31/2021 - 6/21/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CYTK Cytokinetics, Incorporated
49.46
-1.02%
ROIV Roivant Sciences Ltd.
11.43
+0.48%
ARGX argenx SE
669.20
+0.53%
MLTX MoonLake Immunotherapeutics
46.60
-1.10%
IKT Inhibikase Therapeutics, Inc.
2.1700
+13.02%
RVMD Revolution Medicines, Inc.
43.30
+0.53%
BBIO BridgeBio Pharma, Inc.
36.21
+0.67%
DYN Dyne Therapeutics, Inc.
14.34
+1.41%
ZNTL Zentalis Pharmaceuticals, Inc.
1.7006
+2.45%
PRAX Praxis Precision Medicines, Inc.
74.91
-1.69%